SYDE2

Across TCGA pan-cancer cohorts, SYDE2 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated SYDE2 data layer compared with 21 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher SYDE2 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated SYDE2 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, OV, and CHOL are the cancer types where SYDE2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	II,III,IV	1.000	0.296	<.001	36	view →
OV	DFS	Median	II,III,IV	0.204	0.541	.017	12	view →
CHOL	OS	Median	All	0.155	0.725	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

SYDE2–UCEC (DFS)

Open the UCEC breakdown →